[1]
Stoffers, R.H. et al. 2025. Rising incidence of radiation pneumonitis after adjuvant durvalumab in NSCLC patients treated with concurrent chemoradiotherapy. Acta Oncologica. 64, (Feb. 2025), 267–275. DOI:https://doi.org/10.2340/1651-226X.2025.42384.